Explainable AI predicts ICU length of stay and guides clinical decision-making

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel artificial intelligence (AI) model is revolutionizing ICU care by not only improving predictions of patient length of stay, but also equipping clinicians with clear, evidence-based insights to guide critical decisions.

Updated: Oculis closes Phase 3 eye drop trial due to ‘administrative error’ from third party

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 28, 2024

Cyclin Dependent Kinase 4 drugs in development by Therapy Areas, Indications, Stages, MoA, RoA, Molecule Type, and Key Players, 2024

The report also covers products from therapy areas such as Oncology, Infectious Disease, Toxicology, and Genetic Disorders which include the indications Solid Tumor, Human Epidermal

October 1, 2024

Bicycle Therapeutics Plc Patent: High Affinity Nectin-4 Binders for Disease Treatment

Share this article According to GlobalData’s company profile on Bicycle Therapeutics, Nanoparticle drug conjugates was a key innovation area identified from patents. Bicycle Therapeutics‘s grant

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.